Quantcast

Latest Zyvox Stories

2014-05-15 12:34:27

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Antibacterial Drugs: World Market Prospects 2013-2023http://www.reportbuyer.com/pharma_healthcare/generic_drugs/antibacterial_drugs_world_market_prospects.html Report DetailsDiscover new trends, opportunities and revenue prospects for bacteria-killing medicinesWhere's the antibiotics market heading? How are those products performing? Visiongain's updated report gives you forecasted revenues...

2010-10-21 06:00:00

NEW YORK, Oct. 21 /PRNewswire-FirstCall/ -- Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to...

2009-09-02 09:48:00

PHILADELPHIA, Sept. 2 /PRNewswire/ -- Pfizer, Inc. announced today it has agreed to plead guilty to criminal conduct and to pay more than $2 billion in criminal and civil fines, penalties and damages to settle allegations made in multiple whistleblower lawsuits that the pharmaceutical giant defrauded Medicare, Medicaid and other government-funded health care programs in connection with its market practices for four of its drugs. The settlement is the largest qui tam settlement in U.S....

2009-09-02 09:48:00

Includes Allegations of Illicitly Promoting Antibiotic As Clinically Superior When Its Own FDA-Approved Label Said Otherwise; First-Ever Qui Tam Whistleblower Settlement of Its Type PHILADELPHIA, Sept. 2 /PRNewswire-USNewswire/ -- Pfizer Inc. ignored a 2005 FDA Warning Letter to stop promoting its antibiotic Zyvox(R) as clinically superior to the significantly less expensive, generic vancomycin when its own FDA-approved label indicated otherwise. The drug giant also defrauded federal...

2008-10-28 06:00:28

Paratek Pharmaceuticals, a developer of therapeutics for treating bacterial infections, has announced positive Phase II data of the company's lead antibiotic, PTK 0796, a first-in-class aminomethylcycline. The Phase II study compared safety and efficacy of oral and intravenous forms of PTK 0796 to Zyvox in the treatment of patients with complicated skin and skin structure infections (cSSSIs). Paratek's trial met its primary safety and tolerability endpoint, demonstrating no differences...

2008-10-26 12:00:10

BOSTON, Oct. 26 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced positive Phase 2 data for the Company's lead antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC). The Phase 2 study compared safety and efficacy of oral and intravenous (IV) forms of PTK 0796 to Zyvox(R) in the treatment of patients with complicated skin and skin structure infections (cSSSIs). Paratek's trial met its primary safety and tolerability endpoint, demonstrating no differences between PTK...

2008-09-15 09:00:57

WATERTOWN, Mass., Sept. 15 /PRNewswire/ -- Enanta Pharmaceuticals, a leader in the development of small molecule anti-infective drugs, announced today the initiation of a Phase 1 study on investigational oral antibiotic EDP-322, a first-in-class MRSA-active Bicyclolide, a novel macrolide-related drug class with a distinct resistance profile. The clinical development program for EDP-322 will include the treatment of hospital- and community-acquired gram-positive infections, including...

2008-07-04 09:00:43

Mylan has announced that its subsidiary, Mylan Pharmaceuticals, has received tentative approval from the FDA for its abbreviated new drug application for Linezolid tablets, 600mg. Linezolid tablets, an antibiotic, are the generic version of Pharmacia and Upjohn's Zyvox tablets. Currently, Mylan has 93 abbreviated new drug applications pending FDA approval, 21 of which are potential first-to-file opportunities.

2005-07-26 11:29:19

WASHINGTON (Reuters) - U.S. regulators warned Pfizer Inc. about "misleading promotion" of its antibiotic drug Zyvox in a professional journal, according to a letter released on Tuesday. The advertisement does not include information about Zyvox's risks, implies it is superior without supporting evidence, and claims it can treat more infections than for which it was approved, the U.S. Food and Drug Administration letter said. The agency called on the drugmaker to halt the advertisement and...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related